Hyperhomocysteinemia and functional cobalamin deficiency due to granulocytosis-induced alterations in the cobalamin-binding protein

Haematologica

Volumn 91, Issue 3, 2006, Pages 394-396

  Vlasveld, Lodewijk Thomas ^a   Bos, Gerard M J ^b   Ermens, Anton A M ^c   Bakker, Jaap A ^b   Lindemans, Jan ^d  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chronic myelogenous leukemia; Cobalamin; Cobalamin binding proteins; Granulocyte colony stimulating factor; Homocysteine

Indexed keywords

COBALAMIN; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HAPTOCORRIN; HOMOCYSTEINE; HYDROXYUREA; IMATINIB; TRANSCOBALAMIN;

AMINO ACID BLOOD LEVEL; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOCYTOSIS; HUMAN; HYPERHOMOCYSTEINEMIA; LEUKOCYTE COUNT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STEM CELL; VITAMIN DEFICIENCY;

GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; HYPERHOMOCYSTEINEMIA; LEUKEMIA, MYELOID, CHRONIC; TRANSCOBALAMINS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 33645398337     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Clarkson B, Strife A, Wisniewski D, Lambek CL, Liu C. Chronic myelogenous leukaemia as a paradigm of early cancer and possible curative strategies. Leukemia 2003;17:1211-62.
2. Garcia-Mareno G, Daderl S, O'Brien S, Cortes J, Talpaz M, Kantarjian HM. Chronic myelogenous leukaemia: a review and update of therapeutic strategies. Cancer 2003;98:437-57.
3. Gimsing P, Overballe-Petersen C, Hippe E. Cobalamin and cobalamin-binaing proteins in plasma related to the clinical condition in chronic myelogenous leukemia. Leukemia 1995;9:1604-9.
4. Gimsing P. Cobalamin metabolism in chronic myelogenous leukemia. Dan Med Bull 1998;45:459-79.
5. Ermens AAM, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003;36:585-90.
6. Kapadia CR. Vitamin B12 in health and disease. Part I - inherited disorders of function, absorption, and transport. Gastroenterologist 1995;3:329-44.
7. Markle HV. Cobalamin. Crit Rev Clin Lab Sci 1996;33:247-356.
8. Gimsing P, Nexo E. The turnover of 57 Co-labeled cyanocobalamin bound to cobalamin binding proteins in patients with chronic myelogenous leukemia. J Lab Clin Med 1994;123:264-72.
9. Neale G. B12 binding proteins. Gut 1990;31:59-63.
10. Carmel R. Cobalamin deficiency. In: Carmel R & Jacobsen DW. Homocysteine in health and disease. Cambridge University Press, 2001. p. 289-305.
11. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Sem Thromb Hemostast 2000;26:219-25.
12. Perry DJ. Hyperhomocysteinaemia. Ball Clin Haematol 1999;12:451-77.
13. Jacob E, Herbert V. Measurement of unsaturated granulocyte-related (TC I and III) and liver-related (TC II) B12 binders by instant batch separation using a microfine precipitate of silica (QUSO G32). J Lab Clin Med 1975;86:505-12.
14. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
15. Ubbink JB, Vermaak WJ, Bissbort SH. Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-6.
16. Carmel R. Measuring and interpreting holo-transcobalamin (holo-transcobalamin II). Clin Chem 2002;48:407-9.
17. Gimsing P, Hippe E. Cobalamin-dependent metabolism in chronic myelogenous leukemia determined by deoxyuridine suppression test and the formiminoglutamic acid and methylmalonate excretion in the urine. Am J Hematol 1995; 49:121-30.
18. Seetharam B. Receptor-mediated endocytosis of cobalamin (vitamin B12). Ann Rev Nutrit 1999;19:173-95.